These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38662300)
21. Unilateral GPi-DBS Improves Ipsilateral and Axial Motor Symptoms in Parkinson's Disease as Evidenced by a Brain Perfusion Single Photon Emission Computed Tomography Study. Hayashi Y; Mishima T; Fujioka S; Morishita T; Inoue T; Nagamachi S; Tsuboi Y Front Hum Neurosci; 2022; 16():888701. PubMed ID: 35634204 [TBL] [Abstract][Full Text] [Related]
22. Acute Effects of Subthalamic Deep Brain Stimulation on Motor Outcomes in Parkinson's Disease; 13 Year Follow Up. Zhou H; Wang L; Zhang C; Qiu X; Hu W; van der Stelt O; Ramirez-Zamora A; Li D Front Neurol; 2019; 10():689. PubMed ID: 31293511 [No Abstract] [Full Text] [Related]
23. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease. Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765 [TBL] [Abstract][Full Text] [Related]
24. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects. Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467 [TBL] [Abstract][Full Text] [Related]
25. Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson's Disease. Lin Z; Zhang X; Wang L; Zhang Y; Zhou H; Sun Q; Sun B; Huang P; Li D Front Hum Neurosci; 2021; 15():604433. PubMed ID: 33613209 [No Abstract] [Full Text] [Related]
26. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: A meta-analysis of randomized controlled trials. Zhang J; Li J; Chen F; Liu X; Jiang C; Hu X; Ma L; Xu Z Clin Neurol Neurosurg; 2021 Feb; 201():106450. PubMed ID: 33421741 [TBL] [Abstract][Full Text] [Related]
27. At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control. Schmidt SL; Chowdhury AH; Mitchell KT; Peters JJ; Gao Q; Lee HJ; Genty K; Chow SC; Grill WM; Pajic M; Turner DA Brain; 2024 Mar; 147(3):911-922. PubMed ID: 38128546 [TBL] [Abstract][Full Text] [Related]
28. Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials. Xu F; Ma W; Huang Y; Qiu Z; Sun L Neuropsychiatr Dis Treat; 2016; 12():1435-44. PubMed ID: 27382286 [TBL] [Abstract][Full Text] [Related]
29. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan. Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343 [TBL] [Abstract][Full Text] [Related]
30. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Kleiner-Fisman G; Herzog J; Fisman DN; Tamma F; Lyons KE; Pahwa R; Lang AE; Deuschl G Mov Disord; 2006 Jun; 21 Suppl 14():S290-304. PubMed ID: 16892449 [TBL] [Abstract][Full Text] [Related]
31. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252 [TBL] [Abstract][Full Text] [Related]
32. Age-dependent efficacy of subthalamic nucleus deep brain stimulation in young- and late-onset Parkinson's disease based on a 10 year follow-up. Kim MS; Ryu HS; Park KW; Choi N; You S; Kim MJ; Kim YJ; Kim J; Kim K; Chung SJ J Neurol Sci; 2020 Sep; 416():117004. PubMed ID: 32622084 [TBL] [Abstract][Full Text] [Related]
33. Deep Brain Stimulation of Subthalamic Nucleus Improves Quality of Life in General and Mental Health Domains in Parkinson's Disease to the Level of the General Population. Kähkölä J; Katisko J; Lahtinen M Neuromodulation; 2024 Apr; 27(3):520-527. PubMed ID: 37086220 [TBL] [Abstract][Full Text] [Related]
34. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results. Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316 [TBL] [Abstract][Full Text] [Related]
35. A comparison of LEDD and motor scores following STN-DBS treatment in patient with young onset vs. late onset Parkinson's disease. Park YS; Kim HY; Chang WS; Lee PH; Sohn YH; Chang JW Neuromodulation; 2010 Oct; 13(4):255-60. PubMed ID: 21992878 [TBL] [Abstract][Full Text] [Related]
36. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation. Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S Front Neurol; 2022; 13():1042033. PubMed ID: 36686507 [TBL] [Abstract][Full Text] [Related]
37. Quality of Life and Motor Outcomes in Patients With Parkinson's Disease 12 Months After Deep Brain Stimulation in China. Zhang Y; Chen L; Sun B; Wang X; Wang J; Wang J; Woods J; Stromberg K; Shang H Neuromodulation; 2023 Feb; 26(2):443-450. PubMed ID: 36411150 [TBL] [Abstract][Full Text] [Related]
40. Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease. Kim HY; Chang WS; Kang DW; Sohn YH; Lee MS; Chang JW J Korean Neurosurg Soc; 2013 Aug; 54(2):118-24. PubMed ID: 24175026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]